Research Article| Volume 2, ISSUE 1, P233-252, March 1982

Download started.


Transfusion-Transmitted Viral Hepatitis

  • James W. Mosley
    Corresponding author: Epidemiologic Research Laboratory, Rancho Los Amigos Hospital, 7601 E. Imperial Highway, Downey, California 90242
    Professor of Medicine, University of Southern California School of Medicine, Los Angeles, California

    Director, Epidemiology Research Laboratory, Liver Unit, Rancho Los Amigos Hospital, Downey, California
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      Various measures, such as laboratory screening of donors, use of washed red blood cells, passive immunization, and active immunization, can be implemented to prevent transfusion-transmitted viral hepatitis. The difficulties and benefits in using each of these procedures are explored.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Aach R.D.
        • Kahn R.A.
        Post-transfusion hepatitis: Current perspectives.
        Ann. Intern. Med. 1980; 92: 539-546
        • Aach R.D.
        • Szmuness W.
        • Mosley J.W.
        • et al.
        Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients: The Transfusion-transmitted Viruses Study.
        N. Engl. J. Med. 1981; 304: 989-994
        • Allen J.G.
        • Sayman W.A.
        Serum hepatitis from transfusions of blood: Epidemiologic study.
        J.A.M.A. 1962; 180: 1079-1085
        • Alter H.J.
        • Purcell R.H.
        • Feinstone S.M.
        • et al.
        Non-A/non-B hepatitis: A review and interim report of an ongoing prospective study.
        in: Vyas G.N. Cohen S.N. Schmid R. Viral Hepatitis: Etiology, Epidemiology, Pathogenesis and Prevention. Franklin Institute Press, Philadelphia1978: 359-367
        • Alter H.J.
        • Purcell R.H.
        • Holland P.V.
        • et al.
        Transmissible agent in non-A, non-B hepatitis.
        Lancet. 1978; 1: 459-463
        • Alter H.J.
        • Tabor E.
        • Meryman H.T.
        • et al.
        Transmission of hepatitis B virus infection by transfusion of frozen-deglycerolized red blood cells.
        N. Engl. J. Med. 1978; 298: 637-642
        • Bang N.U.
        • Ruegsegger P.
        • Ley A.B.
        • et al.
        Detection of hepatitis carriers by serum glutamic oxalacetic transaminase activity.
        J.A.M.A. 1959; 171: 2303-2306
      1. Bastiaans, M. J. S., Nadi, N., Dodd, R. Y., et al.: A comparative study of HBV-associated serologic markers in HBsAg-positive first-time and repeat blood donors. J. Infect. Dis., in press.

        • Beeson P.B.
        Jaundice occurring one to four months after transfusion of blood or plasma: Report of seven cases.
        J.A.M.A. 1943; 121: 1332-1334
        • Blumberg B.S.
        Polymorphisms of serum proteins and the development of iso-precipitins in transfused patients.
        Bull. N. Y. Acad. Med. 1964; 40: 377-386
        • Bradley D.W.
        • Maynard J.E.
        • Hindman S.H.
        • et al.
        Serodiagnosis of viral hepatitis A: Detection of acute-phase immunoglobulin M anti-hepatitis A virus by radioimmunoassay.
        J. Clin. Microbiol. 1977; 5: 521-530
        • Bradley W.H.
        • Loutit J.F.
        • Maunsell K.
        An episode of “homologous serum jaundice.”.
        Br. Med. J. 1944; 2: 268-269
        • Capps R.B.
        • Sborov V.
        • Scheiffley C.S.
        A syringe-transmitted epidemic of infectious hepatitis.
        J.A.M.A. 1948; 136: 819-824
        • Chalmers T.C.
        • Forrest J.N.
        • Grady G.F.
        The prevention of post-transfusion hepatitis: A challenge to physicians and blood banks.
        Trans. Am. Clin. Climatol. Assoc. 1968; 80: 15-22
        • Chalmers T.C.
        • Koff R.S.
        • Grady G.F.
        A note on fatality in serum hepatitis.
        Gastroenterology. 1965; 49: 22-26
        • Cherubin C.E.
        Risk of post-transfusion hepatitis in recipients of blood containing S. H. antigen at Harlem Hospital.
        Lancet. 1971; 1: 627-630
        • Chembin C.E.
        Acquisition of antibody to hepatitis B antigen in three socioeconomically different medical populations.
        Lancet. 1972; 2: 149-151
        • Craske J.
        • Dilling N.
        • Stern D.
        An outbreak of hepatitis associated with intravenous injection of factor-VIII concentrate.
        Lancet. 1975; 2: 221-223
        • De Ritis F.
        • Mallucci L.
        • Coltorti M.
        Anicteric vims hepatitis in a closed environment as shown by serum transaminase activity.
        Bull. WHO. 1959; 20: 589-602
        • Dietzman D.E.
        • Matthew E.B.
        • Madden D.L.
        • et al.
        The occurrence of epidemic infectious hepatitis in chronic carriers of Australia antigen.
        J. Pediatr. 1979; 80: 577-582
        • Feinstone S.M.
        • Kapikian A.Z.
        • Purcell R.H.
        • et al.
        Transfusion-associated hepatitis not due to viral hepatitis type A or B.
        N. Engl. J. Med. 1975; 192: 767-770
        • Feller A.
        • Rakela J.
        • Uchida T.
        Alcoholic cirrhosis complicated by acute viral hepatitis.
        Hepatology. 1981; 1: 508
        • Findlay G.M.
        • MacCallum F.O.
        Note on acute hepatitis and yellow fever immunization.
        Trans. R. Soc. Trop. Med. Hyg. 1937; 31: 297-308
        • Findlay G.M.
        • MacCallum F.O.
        • Murgatroyd F.
        Observations bearing on the aetiology of infective hepatitis (so-called epidemic catarrhal jaundice).
        Trans. R. Soc. Trop. Med. Hyg. 1939; 32: 575-586
        • Francis Jr., T.
        • Frisch A.W.
        • Quilligan Jr., J.J.
        Demonstration of infectious hepatitis virus in presymptomatic period after transfer by transfusion.
        Proc. Soc. Exp. Biol. Med. 1946; 61: 276-280
      2. Gamma globulin can eliminate semm hepatitis. J.A.M.A., 180:29, 1962.

        • Gocke D.J.
        • Greenberg H.B.
        • Kavey N.B.
        Correlation of Australia antigen with post-transfusion hepatitis.
        J.A.M.A. 1970; 212: 877-879
        • Goldfield M.
        • Bill J.
        • Colosimo F.
        The control of transfusion-associated hepatitis.
        in: Vyas G.N. Cohen S.N. Schmid R. Viral Hepatitis: Etiology, Epidemiology, Pathogenesis and Prevention. Franklin Institute Press, Philadelphia1978: 405-414
        • Grady G.F.
        • Chalmers T.C.
        • the Boston Inter-hospital Liver Group
        Risk of post-transfusion viral hepatitis.
        N. Engl. J. Med. 1964; 271: 337-342
        • Grady G.F.
        • Rodman M.
        • Larsen L.H.
        Hepatitis B antibody in conventional gamma globulin.
        J. Infect. Dis. 1975; 132: 472-477
        • Harden A.G.
        • Barondess J.A.
        • Parker B.
        Transmission of infectious hepatitis by transfusion of whole blood with a note on early appearance of viremia in this disease.
        N. Engl. J. Med. 1955; 253: 923-925
        • Haugen R.K.
        Hepatitis after the transfusion of frozen red cells and washed red cells.
        N. Engl. J. Med. 1979; 301: 393-395
        • Havens W.P.
        Infectious hepatitis.
        Medicine. 1948; 27: 279-326
        • Hilleman M.R.
        • Bertland A.U.
        • Buynak E.B.
        • et al.
        Clinical and laboratory studies of HBsAg vaccine.
        in: Vyas G.N. Cohen S.N. Schmid R. Viral Hepatitis: Etiology, Epidemiology, Pathogenesis and Prevention. Franklin Institute Press, Philadelphia1978: 525-538
        • Hilleman M.R.
        • Buynak E.B.
        • Roehm R.R.
        • et al.
        Purified and inactivated human hepatitis B vaccine: Progress report.
        Am. J. Med. Sei. 1975; 270: 401-404
        • Hollinger F.B.
        • Gitnick G.L.
        • Aach R.D.
        • et al.
        Non-A, non-B hepatitis transmission in chimpanzees: A project of the Transfusion-Transmitted Viruses Study Group.
        Intervirology. 1978; 10: 60-68
        • Hollinger F.B.
        • Mosley J.W.
        • Szmuness W.
        • et al.
        Transfusion-transmitted Viruses Study: Experimental evidence for two non-A, non-B hepatitis agents.
        J. Infect. Dis. 1980; 142: 400-407
      3. Hollinger, F. B., Mosley, J. W., Szmuness, W., et al.: Non-A, non-B hepatitis following blood transfusion: Risk factors associated with donor characteristics. In Szmuness, W., Alter, H. J., and Maynard, J. E. (eds): Proceedings of the International Symposium on Viral Hepatitis. Philadelphia, Franklin Institute Press, in press.

      4. Hollinger, F. B., Yawn, D. H., Oefinger, P., et al.: Post-transfusion hepatitis A. In Szmuness, W., Alter, H. J., and Maynard, J. E. (eds): Proceedings of the International Symposium on Viral Hepatitis. Philadelphia, Franklin Institute Press, in press.

        • Hoofnagle J.H.
        Precipitin system detected in sera from patients with non-A, non-B hepatitis.
        J. Med. Virol. 1981; 7: 313-319
        • Hoofnagle J.H.
        • Seeff L.B.
        • Bales Z.B.
        • et al.
        Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen.
        N. Engl. J. Med. 1978; 298: 1379-1383
        • Hoofnagle J.H.
        • Seeff L.B.
        • Bales Z.B.
        • et al.
        Passive-active immunity from hepatitis B immune globulin: Reanalysis of a Veterans Administration cooperative study of needle-stick hepatitis.
        Ann. Intern. Med. 1979; 91: 813-818
      5. How frequent is posttransfusion hepatitis after the introduction of 3rd generation donor screening for hepatitis B? What is its probable nature? Vox Sang., 32:346–363, 1977.

        • Hruby M.A.
        • Schauf V.
        Transfusion-related short-incubation hepatitis in hemophilic patients.
        J.A.M.A. 1978; 240: 1355-1357
      6. Immune globulins for protection against viral hepatitis: Recommendation of the Public Health Service Advisory Committee on Immunization Practiices. Morbid. Mortal. Weekly Rep., 26:425-428, 441-442, 1977

      7. Immune globulins for protection against viral hepatitis: Recommendation of the Immunization Practices Advisory Committee (ACIP). Morbid. Mortal. Weekly Rep., 30:424, 1981

        • Iwarson S.
        • Lindhohn A.
        • Norkrans G.
        Hepatitis B and non-A, non-B in a Swedish blood center during 10 years of HBsAg screening.
        Vox Sang. 1980; 39: 79-82
        • Jennings E.R.
        • Hindman W.M.
        • Zak B.
        • et al.
        The thymol turbidity test in screening of blood donors.
        Am. J. Clin. Pathol. 1957; 27: 489-502
        • Knodell R.G.
        • Conrad M.E.
        • Ishak K.G.
        Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis.
        Gastroenterology. 1977; 72: 902-909
        • Knodell R.G.
        • Conrad M.E.
        • Ginsberg A.L.
        • et al.
        Efficacy of prophylactic gamma-globulin in preventing non-A, non-B posttransfusion hepatitis.
        Lancet. 1976; 1: 557-561
        • Krugman S.
        • Overby L.R.
        • Mushahwar I.K.
        • et al.
        Viral hepatitis, type B: Studies of its natural history and prevention reexamined.
        N. Engl. J. Med. 1979; 300: 101-106
        • Kuhns W.J.
        • Prince A.M.
        • Brotman B.
        • et al.
        A clinical and laboratory evaluation of immune serum globulin from donors with a history of hepatitis: Attempted prevention of post-transfusion hepatitis.
        Am. J. Med. Sei. 1976; 272: 255-261
        • Lesses M.F.
        • Hamolsky M.N.
        Epidemic of homologous serum hepatitis apparently caused by human thrombin.
        J.A.M.A. 1951; 147: 727-730
        • MacCallum F.O.
        Homologous serum hepatitis.
        Lancet. 1948; 2: 477
        • MacCallum F.O.
        • Bauer D.J.
        Homologous serum jaundice: Transmission experiments with human volunteers.
        Lancet. 1944; 1: 622-627
        • McFarlan A.M.
        • Chesney G.
        Hepatitis following injection of mumps convalescent plasma. II. Epidemiology of the hepatitis.
        Lancet. 1944; 1: 816-817
        • McGraw J.J.
        • Strumia M.M.
        • Burns E.
        The incidence of posttransfusion serum hepatitis.
        Am. J. Clin. Pathol. 1949; 19: 1004-1015
        • Maxwell N.G.
        Incidence of serum hepatitis in recipients of thymol turbidity-screened blood or aged liquid plasma.
        Am. J. Clin. Pathol. 1960; 34: 518-525
        • Miller W.V.
        • Watson L.E.
        • Holland P.V.
        • et al.
        Evaluation of the effectiveness of hepatitis screening tests.
        Vox Sang. 1971; 21: 1-10
        • Mirick G.S.
        • Ward R.
        • McCollum R.W.
        Gamma globulin in control of hepatitis following blood transfusion.
        Vox Sang. 1962; 7: 125-126
        • Morgan H.V.
        • Williamson D.A.J.
        Jaundice following administration of human blood products.
        Br. Med. J. 1943; 1: 750-753
        • Mosley J.W.
        The surveillance of transfusion-associated viral hepatitis.
        J.A.M.A. 1965; 193: 91-94
        • Mosley J.W.
        New patterns of transfusion-associated hepatitis.
        Epatologia. 1966; 12: 527-538
        • Mosley J.W.
        Epidemiology of HAV.
        in: Vyas G.N. Cohen S.N. Schmid R. Viral Hepatitis: Etiology, Epidemiology, Pathogenesis and Prevention. Franklin Institute Press, Philadelphia1978: 85-104
        • Mosley J.W.
        • Redeker A.G.
        • Feinstone S.M.
        • et al.
        Multiple hepatitis viruses in multiple attacks of acute viral hepatitis.
        N. Engl. J. Med. 1977; 296: 75-78
        • Neefe J.R.
        • Gellis S.S.
        • Stokes Jr., J.
        Homologous serum hepatitis and infectious (epidemic) hepatitis: Studies in volunteers bearing on immunological and other characteristics of the etiological agents.
        Am. J. Med. 1946; 1: 3-22
        • Norris R.F.
        • Kassouny D.
        • Reinhold J.G.
        • et al.
        Persistence of abnormal hepatic tests in carriers of viral hepatitis.
        J.A.M.A. 1956; 160: 1118-1121
        • Oliphant J.W.
        • Gilliam A.G.
        • Larson C.L.
        Jaundice following administration of human serum.
        Public Health Rep. 1943; 58: 1233-1242
        • Papaevangelou G.
        • Frosner G.
        • Economidou J.
        • et al.
        Prevalence of hepatitis A and B infections in multiply transfused thalassemic patients.
        Br. Med. J. 1978; 1: 689-691
        • Paul J.R.
        • Havens Jr., W.P.
        • Sabin A.B.
        • et al.
        Transmission experiments in serum jaundice and infectious hepatitis.
        J.A.M.A. 1945; 128: 911-915
        • Prince A.M.
        An antigen detected in the blood during the incubation period of serum hepatitis.
        Proc. Natl. Acad. Sei. USA. 1968; 60: 814-821
        • Prince A.M.
        • Brotman B.
        • Grady G.F.
        • et al.
        Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B vims.
        Lancet. 1974; 2: 241-246
        • Propert S.A.
        Hepatitis after prophylactic serum.
        Br. Med. J. 1938; 2: 667-678
        • Sandler S.G.
        • Rath C.E.
        • Wickerhauser M.
        Post-Konyne hepatitis: The ineffectiveness of screening for die hepatitis B antigen (HBAg).
        Transfusion. 1973; 13: 221-224
        • Sborov V.M.
        • Giges B.
        • Mann J.D.
        Incidence of hepatitis following use of pooled plasma: A follow-up study in five hundred eighty-seven Korean casualties.
        Arch. Intern. Med. 1953; 92: 678-683
        • Seeff L.B.
        • Zimmerman H.J.
        • Wright E.C.
        • et al.
        A randomized double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis.
        Gastroenterology. 1977; 72: 111-121
        • Skidmore S.J.
        • Jones T.E.G.
        • Boxall E.H.
        Non-A, non-B hepatitis in patients receiving blood products.
        J. Med. Virol. 1980; 6: 85-89
        • Spurling N.
        • Shone J.
        • Vaughan J.
        The incidence, incubation period and symptomatology of homologous serum jaundice.
        Br. Med. J. 1946; 2: 409-412
        • Stevens C.E.
        • the Transfusion-transmitted Viruses Study Group
        Antibody to hepatitis B core antigen in donor blood and the risk of non-A non-B hepatitis in recipients.
        Transfusion. 1981; 21: 607
        • Stevens C.E.
        • Silbert J.A.
        • Miller D.R.
        • et al.
        Serologic evidence of hepatitis A and B virus infections in thalassemia patients: A retrospective study.
        Transfusion. 1978; 18: 356-360
        • Stmmia M.M.
        • Burns M.E.
        • Sample A.B.
        • et al.
        The incidence of posttransfusion hepatitis. II. A 13-year survey including 2 years during which blood donors were screend by means of liver function studies.
        Am. J. Clin. Pathol. 1958; 30: 133-142
        • Szmuness W.
        • Dienstag J.L.
        • Purcell R.H.
        • et al.
        Distribution of antibody to hepatitis A antigen in urban adult populations.
        N. Engl. J. Med. 1976; 295: 755-759
        • Szmuness W.
        • Stevens C.E.
        • Harley E.J.
        • et al.
        Hepatitis B vaccine — Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.
        N. Engl. J. Med. 1980; 303: 833-841
        • Szmuness W.
        • Stevens C.E.
        • Oleszko W.R.
        • et al.
        Passive-active immunization against hepatitis B: Immunogenicity studies in adult Americans.
        Lancet. 1981; 1: 575-577
        • Szmuness W.
        • Stevens C.E.
        • Zang E.A.
        • et al.
        A controlled clinical trial of the efficacy of the hepatitis B vaccine (Hepta-vax B): A final report.
        Hepatology. 1981; 1: 377-385
        • Tabor E.
        • Gerety R.J.
        • Drucker J.A.
        • et al.
        Transmission of non-A, non-B hepatitis from man to chimpanzee.
        Lancet. 1978; 1: 463-466
        • Tateda A.
        • Kikuchi K.
        • Numazaki Y.
        • et al.
        Non/B hepatitis in Japanese recipients after blood transfusions: Clinical and serological studies after the introduction of laboratory screening of donor blood for hepatitis B surface antigen.
        J. Infect. Dis. 1979; 139: 511-518
      8. The Outbreak of Jaundice in the Army (circular letter no. 95). J.A.M.A., 120:51–53, 1942.

        • Tullis J.L.
        • Hinman J.
        • Sproul M.T.
        • et al.
        Incidence of posttransfusion hepatitis in previously frozen blood.
        J.A.M.A. 1970; 214: 719-723
        • Wands J.R.
        • Carlson R.I.
        • Schoemaker H.
        • et al.
        Immunodiagnosis of hepatitis B with high-affinity IgM monoclonal antibodies.
        Proc. Natl. Acad. Sei. USA. 1981; 78: 1214-1218
      9. Wrobel, D. M., Buchner, B. K., and Mankikar, S. D.: A retrospective study of cases of post-transfusion hepatitis in the Toronto Centre of the Canadian Red Cross Blood Transfusion Service. In Szmuness, W., Alter, H. J., and Maynard, J. E. (eds): Proceedings of the International Symposium on Viral Hepatitis. Philadelphia, Franklin Institute Press, in press.

        • Wroblewski F.
        The clinical significance of transaminase activities of serum.
        Am. J. Med. 1959; 27: 911-923